IL324578A - A new crystalline form of risperidone and a process for its preparation - Google Patents
A new crystalline form of risperidone and a process for its preparationInfo
- Publication number
- IL324578A IL324578A IL324578A IL32457825A IL324578A IL 324578 A IL324578 A IL 324578A IL 324578 A IL324578 A IL 324578A IL 32457825 A IL32457825 A IL 32457825A IL 324578 A IL324578 A IL 324578A
- Authority
- IL
- Israel
- Prior art keywords
- risdiplam
- crystalline form
- crystalline
- gal1024wo
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202321033768 | 2023-05-13 | ||
| PCT/IN2024/050457 WO2024236590A1 (en) | 2023-05-13 | 2024-04-30 | Novel crystalline form of risdiplam and process for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324578A true IL324578A (en) | 2026-01-01 |
Family
ID=93518766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324578A IL324578A (en) | 2023-05-13 | 2024-04-30 | A new crystalline form of risperidone and a process for its preparation |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4713331A1 (de) |
| CN (1) | CN121399140A (de) |
| IL (1) | IL324578A (de) |
| WO (1) | WO2024236590A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20251594T1 (hr) * | 2017-09-22 | 2026-01-30 | F. Hoffmann - La Roche Ag | Postupak priprave derivata 7-(4,7-diazaspiro[2.5]oktan-7-il)-2-(2,8-dimetilimidazo[1,2-b]piridazin-6-il)pirido[1,2-a]pirimidin-4-ona |
| IL319888A (en) * | 2018-10-19 | 2025-05-01 | Hoffmann La Roche | Forms of pyrido[2,1-A]pyrimidin-4-one derivatives, their formulations and process for their preparation |
| EP4004003A1 (de) * | 2019-07-31 | 2022-06-01 | Teva Pharmaceuticals International GmbH | Feste formen von risdiplam und verfahren zur herstellung davon |
| WO2022162107A1 (en) * | 2021-02-01 | 2022-08-04 | Sandoz Ag | Crystalline form of risdiplam |
-
2024
- 2024-04-30 WO PCT/IN2024/050457 patent/WO2024236590A1/en not_active Ceased
- 2024-04-30 EP EP24806796.9A patent/EP4713331A1/de active Pending
- 2024-04-30 IL IL324578A patent/IL324578A/en unknown
- 2024-04-30 CN CN202480032400.2A patent/CN121399140A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN121399140A (zh) | 2026-01-23 |
| EP4713331A1 (de) | 2026-03-25 |
| WO2024236590A1 (en) | 2024-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0683780B1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| JP5701246B2 (ja) | 有機化合物 | |
| AU2004268024A1 (en) | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor | |
| AU2014336747B2 (en) | Crystal form of (r)-praziquantel and preparation method and application thereof | |
| JP2001512109A (ja) | 結晶性ジベンゾチアゼピン誘導体およびその抗精神病薬としての使用 | |
| CN120441536A (zh) | 大规模制备化合物半琥珀酸盐和乙酸盐的方法和中间体 | |
| US9493417B2 (en) | Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide | |
| BG100639A (bg) | Нова кристална форма на безводна 7-(/1 алфа,5 алфа,6 алфа/-6-амино- 3-азабицикло/3.1.0/хекс-3-ил)-6-флуоро-1-(2,4-дифлуорофенил)-1,4- дихидро-4-оксо-1,8-нафтиридин-3-карбоксилна киселина, метансулфоновокисела сол | |
| JPH09510222A (ja) | ２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピン化合物の酸付加塩 | |
| JPH0526782B2 (de) | ||
| IL324578A (en) | A new crystalline form of risperidone and a process for its preparation | |
| KR101743783B1 (ko) | 신규 화합물 | |
| WO2022234602A1 (en) | A process for the preparation of solid state forms of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl) pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl)}-n-(pyridine-2-yl)benzamide | |
| EP0495889A1 (de) | Iminomethanodibenzo[a,d]cycloheptenderivate als neuroschützende mittel | |
| WO2020141562A1 (en) | Novel crystalline forms and process for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl)}-n-(pyridine-2-yl)benzamide | |
| EP0847400B1 (de) | Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin | |
| EP1272490B1 (de) | Natrium salz eines 5-aminosalicylsäure azoderivates | |
| JP5826262B2 (ja) | ソリフェナシン塩 | |
| WO2008127618A1 (en) | Crystalline and amorphous forms of naltrexone hydrochloride | |
| JPH04270222A (ja) | 脳機能改善剤 | |
| WO2025163672A1 (en) | Solid-state forms of resmetirom and processes for preparation thereof | |
| WO2020170270A1 (en) | Novel crystalline polymorphs of 1-[(3r)-3-[4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one and process for preparation thereof | |
| HK1262749B (en) | Crystalline form of a compound, preparation, and uses thereof | |
| WO2005051394A1 (en) | Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist |